International scientific guideline: Questions and answers document on the clinical development of fixed combinations of drugs belonging to different therapeutic classes in the field of cardiovascular treatment and prevention

About this guideline

Overseas effective date: 23 June 2005

Categories: Clinical efficacy and safety | Cardiovascular system | Coronary artery disease (CAD)

Access this international scientific guideline

For more information see International scientific guidelines adopted in Australia.

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.